Blue Sky Hosts Community and Stakeholder Water Sampling Event at the Ivana Uranium-Vanadium Project, Argentina

Blue Sky Uranium Corp. (TSX-V: BSK, FSE: MAL2; OTC: BKUCF), (‘Blue Sky’ or the ‘Company’) is pleased to announce that on May 28, 2025, Ivana Minerales S.A. completed the first participatory groundwater sampling at the Ivana Uranium-Vanadium Project, (the “Project”). This was a precursor to the recently announced infill drilling program that marks a major…

GMV Minerals Inc. Extends Exclusive Option to Acquire Mexican Hat Mining Claims – Commissions Updated Preliminary Economic Assessment

GMV Minerals Inc. (the ‘Company’ or ‘GMV’) (TSXV:GMV)(OTCQB:GMVMF) announces that it has elected to extend its exclusive initial five (5) year option (‘Option’) to purchase certain unpatented mineral claims (‘Claims’) located in Arizona (the ‘Mexican Hat Property’) for an additional three (3) years by making an additional Option extension payment of US$5,000 to Hernandez Trust….

Blue Sky Uranium Closes 1st Tranche & Increases Oversubscribed Non-Brokered Private Placement

Blue Sky Uranium Corp. (TSX-V: BSK, FSE: MAL2; OTC: BKUCF), (‘Blue Sky’ or the ‘Company’) announces that due to high investor demand, the Company has increased the private placement amount announced on June 5, 2025 (the “Offering”), from $1,020,000 to $2,040,000 consisting of 34 million units (the “Units”) at $0.06 per Unit. The Company further…

Aston Bay and American West Metals Announce Drilling Preparations Underway at the Storm Project, Nunavut, Canada

Camp opening and logistics have commenced with geophysics and drilling to follow in the coming weeks Aston Bay Holdings Ltd. (TSXV:BAY)(OTCQB:ATBHF) (‘Aston Bay’ or the ‘Company’) is pleased to announce the commencement of activities at the Storm Copper Project (‘Storm’ or the ‘Project’) on Somerset Island, Nunavut. American West Metals Limited (‘American West’), the Project…

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases

Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for RAD101 to distinguish between recurrent disease and treatment effect of brain metastases originating from solid…

New INNspired Article Spotlights Rare Earth Recycling as a Strategic Investment Opportunity in U.S. Critical Mineral Supply Chain

(TheNewswire) As global demand for rare earth magnets accelerates—driven by electric vehicles, renewable energy systems, and high-performance computing—the need for secure, domestic sources of these critical materials has become a strategic priority for the United States. The article explores how rare earth recycling is emerging as a viable and scalable response to supply chain risks…